Poland· PL-100503481

Rizegmef

A dapagliflozin product containing dapagliflozinum, registered in Poland by Sandoz Polska Sp. z o.o.. The same ATC class is registered in 16 of our 19 countries.

ATC A10BK01

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about dapagliflozinumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Dapagliflozin is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BK01 (dapagliflozin), each read from that country’s own register.

This record: Poland, from URPL (Poland)
9 of them publish a price we can compare per daily dose

Search dapagliflozin products by name

Dapagliflozin · ATC A10BK01

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dapagliflozin costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.33 in United States to $4.38 in Switzerland — a ×13 gap.

3 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Dapagliflozin · price per daily dose (10 mg)

USD · FX 28 Sept 2026

CH Switzerland$4.38
IT Italy$3.42
US United States$0.33 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Dapagliflozinum
Manufacturer: Sandoz Polska Sp. z o.o.
Country: Poland (PL)
ATC code: A10BK01
ATC class: Dapagliflozin
Defined daily dose: 10 mg, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 2

gtin
05909991603199
gtin
07622436154107

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

426 interactions on record for dapagliflozin.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check dapagliflozin against other medicines How interaction checks work

Dapagliflozin · interactions on record

426 records

1 severe
378 moderate
47 minor

Most severe, free to view

SucralfateA02BX02moderate
PapaverineA03AD01moderate
ThiethylperazinA04AB03moderate
TriflupromazinA04AD06moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dapagliflozin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dapagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Dapagliflozin +pharma, Dapagliflozin Devatis
Belgium · Dapagliflozin Ab, Dapagliflozin Eg
Bulgaria · Dapagliflozin Sandoz, Dapagliflozin Tchaikapharma
Cyprus · Daforbis, Dapagliflozin Farmoz
Czechia · Dagetia, Dagrafors
Germany · Daglin, Dapagliflozin 123-Acurae Pharma
Denmark · Dapagliflozin, Dapagliflozin "sandoz"
Estonia · Dagrafors, Dapagliflozin Alembic
Spain · Daforbis, Dapagliflozina Aurovitas
Finland · Dapagliflozin Devatis, Dapagliflozin Krka
France · Dapagliflozine Arrow, Dapagliflozine Biogaran
United Kingdom (Northern Ireland) · Daforbis, Dapagliflozin
Greece · Brolertix, Daforbis
Croatia · Daforbis, Dagrafors
Hungary · Dagrafors, Dapagliflozin Sandoz
Ireland · Dapagliflozin Clonmel, Dapagliflozin Krka
Iceland · Dapagliflozin Krka, Dapagliflozin Krka D.D.
Italy · Dapagliflozin Aurobindo, Dapagliflozin Doc
Liechtenstein · Dapagliflozin Viatris, Edistride
Lithuania · Dagrafors, Dapagliflozin Accord
Luxembourg · Dapagliflozin Eg
Latvia · Daglin, Dagrafors
Malta · Dapagliflozin Ascend, Dapagliflozin Aurobindo
Netherlands · Dapagliflozin Alembic, Dapagliflozin Amarox
Norway · Dapagliflozin Alembic, Dapagliflozin Devatis
Portugal · Dalzior, Dapagliflozin Ipca
Romania · Daforbis, Dagetia
Sweden · Daforbis, Dapagliflozin Adalvo
Slovenia · Dagrafors, Dapagliflozin Hcs
Slovakia · Dagetia, Dagrafors

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/afeb0ab2-c692-496c-b032-6a1df755e7ce
GET /v1/drugs/afeb0ab2-c692-496c-b032-6a1df755e7ce?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "10 mg",
  "packaging": "05909991603199 ¦ Rp ¦ 167367\n28 tabl.\n07622436154107 ¦ Rp ¦ 167368\n30 tabl.",
  "substance": "Dapagliflozinum 10 mg",
  "common_name": "Dapagliflozinum",
  "pl_product_id": "100503481",
  "pozwolenie_nr": "29754",
  "auth_procedure": "DCP",
  "authorisation_validity": "2031-06-11"
}

API reference MCP server Plans

See everything about dapagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console